Kaneko Tomoyuki, Fujita Kiichiro, Homma Yukio
Department of Urology, Japanese Red Cross Medical Center, Tokyo, Japan.
Int J Urol. 2006 Mar;13(3):294-5. doi: 10.1111/j.1442-2042.2006.01283.x.
A 76-year-old man received intravesical bacillus Calmette-Guérin (BCG) instillations for recurrent superficial bladder cancer. He had undergone right nephroureterectomy for right renal pelvic cancer 9 months previously. He presented with anuria and left hydronephrosis after the fourth instillation, with serum creatinine increasing up to 15.7 mg/dL. Percutaneous nephrostomy was indwelled, and antegrade pyelography showed left vesicoureteral obstruction. There was no sign of recurrent bladder cancer or ureteral cancer. He started spontaneous voiding on day 4 and the nephrostomy was removed on day 8. Most of the side-effects of intravesical BCG therapy are minor, and major adverse reactions are rare. Life-threatening ureteral obstruction would be a rare complication of BCG immunotherapy. Although BCG intravesical instillation after nephroureterectomy is a common practice, special care should be taken of renal function in patients with unilateral kidney during BCG therapy.
一名76岁男性因复发性浅表性膀胱癌接受膀胱内卡介苗(BCG)灌注治疗。9个月前,他因右肾盂癌接受了右肾输尿管切除术。在第四次灌注后,他出现无尿和左肾积水,血清肌酐升至15.7mg/dL。留置了经皮肾造瘘管,顺行肾盂造影显示左膀胱输尿管梗阻。没有复发性膀胱癌或输尿管癌的迹象。他在第4天开始自主排尿,第8天拔除了肾造瘘管。膀胱内BCG治疗的大多数副作用较小,严重不良反应罕见。危及生命的输尿管梗阻是BCG免疫治疗的罕见并发症。虽然肾输尿管切除术后膀胱内灌注BCG是一种常见做法,但在BCG治疗期间,对单侧肾患者的肾功能应特别关注。